Back to search
FDAFDA · Food and drugs·Recall number D-0496-2026

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50.

Published April 29, 2026 · Recall initiated: April 2, 2026

Summary

FDA records drug Class II recall D-0496-2026, published April 29, 2026 and initiated April 2, 2026. Recalling firm: B BRAUN MEDICAL INC; Status: Ongoing; Reported quantity: 17,124 bags; Lot: Lot # J5H166, J5H167, Exp Date: 30NOV2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

What to do

Voluntary: Firm initiated · Letter

Get an email if DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DEXTROSE
Manufacturer
B BRAUN MEDICAL INC
Distributor
US Nationwide.
Lot
Lot # J5H166, J5H167, Exp Date: 30NOV2026.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical Inc., Bethlehem, PA 18018-3524, USA, NDC: 0264-7387-50. recalled?

Yes. FDA published recall D-0496-2026 on April 29, 2026. Reported hazard: Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DEXTROSE.